We are live on ! Find out more
BYAH

Park Ha Biological Technology Co

4 hedge funds and large institutions have $666K invested in Park Ha Biological Technology Co in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more capital invested

Capital invested by funds: $502K → $666K (+$165K)

0% more funds holding

Funds holding: 44 (0)

0% less ownership

Funds ownership: 0%0% (-0%)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
4
Holders Change
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$222K +$114K +42 New
Citadel Advisors
2
Citadel Advisors
Florida
$220K -$87.1K -32 -43%
HF
3
HRT Financial
New York
$195K -$46.3K -17 -31%
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$30K +$16.3K +6 New
Jane Street
5
Jane Street
New York
-$161K -64 Closed
UBS Group
6
UBS Group
Switzerland
-$19.4K -8 Closed

BYAH Hedge Fund Activity: Q1 2025 in Review

4 of the 7,461 institutional investors tracked by Wall St. Rank reported a position in Park Ha Biological Technology Co (BYAH) for Q1 2025, worth a combined $666K — up 33% from $502K a quarter earlier.

Fund positioning in BYAH was balanced in Q1 2025: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 2 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $114K. The largest seller was Jane Street, exiting entirely with an estimated $161K sold.

  • 4 institutional investors held Park Ha Biological Technology Co (BYAH) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $666K of Park Ha Biological Technology Co stock for Q1 2025, up 33% quarter-over-quarter.
  • 2 funds opened new Park Ha Biological Technology Co positions in Q1 2025 and 2 closed out, a net change of 0 holders.
  • The largest Park Ha Biological Technology Co buyer in Q1 2025 was Geode Capital Management, an estimated $114K added.
  • The largest Park Ha Biological Technology Co seller in Q1 2025 was Jane Street, an estimated $161K sold.

Based on aggregated 13F filings for Q1 2025.